Ohcanbohtosat - A. M. Lila

harmacoeconomic feasibility of using the drug upadacitinib in patients with rheumatoid arthritis in the healthcare system of the Russian Federation Dahkki A. M. Lila, S. K. Zyryanov, I. N. Dyakov

Connect to this object online.

Is it worthwhile rethinking the positive experience of the last 50 years of using chondroitin sulfates against atherosclerosis? Dahkki A. M. Lila, I. Yu. Torshin, O. A. Gromova

Connect to this object online.

Prospects for the use of chondroitin sulfate and glucosamine sulfate in the treatment of patients with obesity-associated osteoarthritis (metabolic syndrome) Dahkki I. Yu. Torshin, О. A. Gromova, A. M. Lila

Connect to this object online.

Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate Dahkki I. Yu. Torshin, A. M. Lila, O. A. Gromova

Connect to this object online.

Perioperative pharmacotherapy for endoprosthetics: potential of chondroitin sulfate and glucosamine sulfate Dahkki I. Yu. Torshin, T. B. Minasov, N. V. Zagorodniy, A. M. Lila, O. A. Gromova

Connect to this object online.

Perspectives of osteoarthritis prevention and therapy personification based on the analysis of comorbid background, genetic polymorphisms and microelement status Dahkki I. Yu. Torshin, A. M. Lila, A. V. Naumov, I. S. Sardaryan, T. E. Bogacheva, T. R. Grishina, I. V. Gogoleva, O. A. Limanova, O. A. Gromova

Connect to this object online.

Meta-analysis of clinical trials of osteoarthritis treatment effectiveness with Chondroguard Dahkki I. Yu. Torshin, A. M. Lila, A. V. Naumov, A. Yu. Kochish, L. I. Alekseeva, E. A. Taskina, I. V. Sarvilina, A. N. Galustyan, A. N. Gromov, A. K. Khadzhidis, L. V. Vasilieva, E. F. Yevstratova, M. I. Udovika, O. A. Gromova

Connect to this object online.